Wolters Kluwer Health Releases New Version Of Master Drug Database; 2.5 Version More User Friendly; Offers Daily Updates And Additional Patient Safety Focus

PHILADELPHIA--(BUSINESS WIRE)--April 11, 2005--Wolters Kluwer Health (WKHealth), the leading drug and health information provider, today announced the release of the latest version of its Master Drug Database (MDDB(R)) for healthcare industry professionals. The enhanced MDDB 2.5 version contains system updates and patient safety focused drug data content. Additionally, daily content updates will provide healthcare professionals with important and timely information about medications, enhancing patient safety and improving overall care. Updates for previous versions of MDDB will continue to be available on a weekly, monthly or quarterly basis. “Master Drug Database 2.5 will provide a user-friendly interface for our customers and improve their access to the most up-to-date information on drugs and other safety issues through daily updates,” said Ken Killion, CEO of Wolters Kluwer Health’s Clinical Tools business unit. “This up-to-date information, in turn, enables healthcare professionals to more accurately assess available medications and enhance patient safety.”